TROYANOSYVIRUS
Back to CVEs

CVE-2026-21923

MEDIUM
6.5

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVE Details

CVSS v3.1 Score6.5
SeverityMEDIUM
CVSS VectorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Attack VectorNETWORK
ComplexityLOW
Privileges RequiredNONE
User InteractionNONE
Published1/20/2026
Last Modified1/29/2026
Sourcenvd
Honeypot Sightings0

Affected Products

oracle:life_sciences_central_designer

IOC Correlations

No correlations recorded

This product uses data from the NVD API but is not endorsed or certified by the NVD.